VERFAHREN ZUR BEHANDLUNG VON ERKRANKUNGEN MIT KNOCHENABBAU UNTER VERWENDUNG EINES GM-CSF- ANTAGONISTEN

The invention is based on the discovery that GM-CSF antagonists can be used for the treatment of bone loss disorders, such as osteopenia. Accordingly, the invention provides methods of administering a GM-CSF antagonist, e.g., a GM-CSF antibody, to a patient that has a bone loss disorder and pharmace...

Full description

Saved in:
Bibliographic Details
Main Authors BEBBINGTON, CHRISTOPHER R, YARRANTON, GEOFFREY T
Format Patent
LanguageGerman
Published 15.05.2012
Online AccessGet full text

Cover

More Information
Summary:The invention is based on the discovery that GM-CSF antagonists can be used for the treatment of bone loss disorders, such as osteopenia. Accordingly, the invention provides methods of administering a GM-CSF antagonist, e.g., a GM-CSF antibody, to a patient that has a bone loss disorder and pharmaceutical compositions comprising such antagonists.
Bibliography:Application Number: AT20090702831T